- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/515 - Barbituric acidsDerivatives thereof, e.g. sodium pentobarbital
Patent holdings for IPC class A61K 31/515
Total number of patents in this class: 321
10-year publication summary
|
34
|
25
|
24
|
23
|
28
|
37
|
30
|
18
|
16
|
6
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Jazz Pharmaceuticals Research UK Limited | 254 |
13 |
| Ovid Therapeutics Inc | 173 |
11 |
| Clexio Biosciences Ltd. | 100 |
11 |
| DexCom, Inc. | 1717 |
9 |
| Glaxosmithkline Intellectual Property (no.2) Limited | 302 |
7 |
| The Johns Hopkins University | 5844 |
7 |
| Locl Pharma, Inc. | 19 |
7 |
| Glaxosmithkline LLC | 529 |
6 |
| The Scripps Research Institute | 1343 |
6 |
| GW Research Limited | 146 |
5 |
| Sun Pharma Advanced Research Company Ltd. | 188 |
5 |
| University of Iowa Research Foundation | 851 |
4 |
| Salarius Pharmaceuticals, Inc. | 10 |
4 |
| The Regents of the University of California | 20590 |
3 |
| Centre National de La Recherche Scientifique | 10914 |
3 |
| Consejo Nacional de Investigaciones Cientificas y Tecnicas (conicet) | 310 |
3 |
| FTF Pharma Private Limited | 30 |
3 |
| Inserm (institut National de La Sante et de La Recherche Medicale) | 3333 |
3 |
| MSD Italia S.r.l. | 51 |
3 |
| Nivagen Pharmaceuticals, Inc. | 24 |
3 |
| Other owners | 205 |